PubMed laboratory research record [PMID: 42208070] PubMed record related to this compound for laboratory literature review
Common sites for injection include the abdomen, thighs, or upper arms
Therefore, telehealth platforms may be more convenient since they already have a compounding partner and coordinate the prescribing, delivery, and follow-up processes
doi: 10.1016/S0140-6736(19)31271-1 18 MosenzonOBlicherTMRosenlundSErikssonJWHellerSHelsOHet al
In between-drug comparisons, tirzepatide at doses of 15 mg, 10 mg and 5 mg demonstrated greater efficacy than semaglutide at doses of 2.0 mg (MD = 4.60 kg [95% CI 7.94, 1.26]), 1.0 mg (MD = 3.53 kg [95% CI 4.80, 2.25]) and 0.5 mg (MD = 2.75 kg [95% CI 4.23, 1.28]), respectively (ESM Table 11)